Acquired MET Exon 14 Alteration Drives Secondary Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in EGFR-Mutated Lung Cancer. Academic Article uri icon

Overview

publication date

  • May 10, 2019

Identity

PubMed Central ID

  • PMC6541452

Scopus Document Identifier

  • 85074301334

Digital Object Identifier (DOI)

  • 10.1200/PO.19.00011

PubMed ID

  • 31157314

Additional Document Info

volume

  • 3